NYSE:CPHI

China Pharma Holdings Stock Insider Trading

Healthcare > Drug Manufacturers - Specialty & Generic

Buy CPHI

*Your capital is at risk

$0.88

+0.0213 (+2.48%)

At Close: Jun 03, 2026

China Pharma Holdings Stock Insider Power

Based on the 82 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 97.56M and sold 4.12M CPHI shares in the last 82 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 82 transactions)	0
● Buy	97.56M shares
● Sell	4.12M shares
88% Buy Activity Negligible or No Correlation
No Significant Signals No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date	Type	Person	Role	Amount
Nov 15, 2010 Buy	Stock Option M-Exempt	Waung Frank Chief Financial Officer	C-Suite Officer	40 000 Value: $110.0K
Nov 15, 2010 Buy	Stock Option M-Exempt	Waung Frank Chief Financial Officer	C-Suite Officer	40 000 Value: $110.0K
Nov 15, 2010 Buy	Common Stock M-Exempt	Waung Frank Chief Financial Officer	C-Suite Officer	4 052 Value: $12.4K
Apr 28, 2010 Sell	Stock Option(Right to Buy) D-Return	Waung Frank Chief Financial Officer	C-Suite Officer	150 000 Value: $520.5K
Apr 28, 2010 Sell	Stock Option(Right to Buy) D-Return	Waung Frank Chief Financial Officer	C-Suite Officer	150 000 Value: $520.5K
Apr 28, 2010 Buy	Stock Option A-Award	Waung Frank Chief Financial Officer	C-Suite Officer	200 000 Value: $694.0K
Apr 28, 2010 Buy	Stock Option A-Award	Waung Frank Chief Financial Officer	C-Suite Officer	200 000 Value: $694.0K
Feb 09, 2010 Buy	Common Stock, par value $0.001 per share A-Award	Tsui Heung Mei	Director	1 500 000 Value: $4.50M
Feb 09, 2010 Buy	Common Stock, par value $0.001 per share A-Award	Tsui Heung Mei	Director	1 500 000 Value: $4.50M
Oct 13, 2009 Sell	Stock Option(Right to Buy) D-Return	Waung Frank Chief Financial Officer	C-Suite Officer	10 000 Value: $27.5K
Oct 13, 2009 Sell	Stock Option(Right to Buy) D-Return	Waung Frank Chief Financial Officer	C-Suite Officer	10 000 Value: $27.5K
Oct 13, 2009 Buy	Option (Right to Buy) A-Award	Waung Frank Chief Financial Officer	C-Suite Officer	50 000 Value: $137.5K
Oct 13, 2009 Buy	Option (Right to Buy) A-Award	Waung Frank Chief Financial Officer	C-Suite Officer	50 000 Value: $137.5K
Oct 13, 2009 Buy	Option (Right to Buy) A-Award	Waung Frank Chief Financial Officer	C-Suite Officer	50 000 Value: $137.5K
Oct 13, 2009 Buy	Option (Right to Buy) A-Award	Waung Frank Chief Financial Officer	C-Suite Officer	50 000 Value: $137.5K
Apr 28, 2009 Buy	Common Stock	Waung Frank Chief Financial Officer	C-Suite Officer	0 Value: $0
Apr 28, 2009 Buy	Common Stock	Waung Frank Chief Financial Officer	C-Suite Officer	0 Value: $0
Feb 01, 2008 Buy	Common Stock	Dong Baowen Director	Director	0 Value: $0
Feb 01, 2008 Buy	Common Stock	Dong Baowen Director	Director	0 Value: $0
Feb 01, 2008 Buy	Common Stock J-Other	Zhang Yingwen	Director	0 Value: $0
Feb 01, 2008 Buy	Common Stock J-Other	Zhang Yingwen	Director	0 Value: $0
Feb 01, 2008 Buy	Common Stock J-Other	Bennett G Michael	Director	0 Value: $0
Feb 01, 2008 Buy	Common Stock J-Other	Bennett G Michael	Director	0 Value: $0
Nov 26, 2007 Buy	Common Stock, par value $0.001 per share A-Award	Tsui Heung Mei	Director	4 465 734 Value: $6.79M
Nov 26, 2007 Buy	Common Stock, par value $0.001 per share A-Award	Tsui Heung Mei	Director	4 465 734 Value: $6.79M

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT CHINA PHARMA HOLDINGS, INC

China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products primarily to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. Its products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit;...

Read Full Profile Here